"10.1371_journal.pone.0047464","plos one","2012-10-15T00:00:00Z","Marcella Maddaluno; Gianluca Grassia; Maria Vittoria Di Lauro; Antonio Parisi; Francesco Maione; Carla Cicala; Daniele De Filippis; Teresa Iuvone; Angelo Guglielmotti; Pasquale Maffia; Nicola Mascolo; Armando Ialenti","Department of Experimental Pharmacology, University of Naples Federico II, Naples, Italy; Angelini, ACRAF, S.Palomba-Pomezia, Rome, Italy; Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom","Conceived and designed the experiments: GG MM AI NM AG. Performed the experiments: GG MM MVDL DDF AP FM. Analyzed the data: GG MM AG AI PM CC TI NM MVDL DDF AP FM. Wrote the paper: GG MM AI NM PM AG.","This study was funded by Angelini, the employer of author Angelo Guglielmotti. Bindarit is an Angelini product. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2012","10","Marcella Maddaluno","MM",12,TRUE,5,6,12,6,TRUE,TRUE,FALSE,0,NA,FALSE
